ProteoMiner^™ and SELDI-TOF-MS: A robust and highly reproducible combination for biomarker discovery from whole blood serum

References

• Aivado M, Spentzos D, Alterovitz G, Out HH, Grall F, Giagounidis AA, Wells M, Cho JY, Germing U, Czibere A et al. (2005). Optimization and evaluation of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) with reversed-phase protein arrays for protein profiling. Clin Chem Lab Med 43(2):133–40.
   PubMed Web of Science ®Google Scholar
• Aivado M, Spentzos D, Germing U, Alterovitz G, Meng XY, Grall F, Giagounidis AA, Klement G, Steidl U, Otu HH et al. (2007). Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. PNAS 104(4):1307–12.
   PubMed Web of Science ®Google Scholar
• Allen J, Davey HM, Broadhurst D, Heald JK, Rowland JJ, Oliver SG, Kell DB (2003). High-throughput classification of yeast mutants for functional genomics using metabolic footprinting. Nat Biotechnol 21(6):692–6.
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG. (2002). The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics 1(11):845–67.
   PubMed Web of Science ®Google Scholar
• De Bock M, de Seny D, Meuwis MA, Chapelle JP, Louis E, Malaise M, Merville MP, Fillet M. (2010). Challenges for biomarker discovery in body fluids using SELDI-TOF-MS. J Biomed Biotechnol epub ahead of print doi:10.1155/2010/906082. Review. E-pub ahead of print.
   PubMed Web of Science ®Google Scholar
• Engwegen JYMN, Mehra N, Haanen JBAG, Bonfrer JMG, Schellens JHM, Voest EE, Beijnen JH. (2007). Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations. Lab Invest 87(2):161–72.
   PubMed Web of Science ®Google Scholar
• Gast MCW, Engwegen JYMN, Schellens JHM, Beijnen JH. (2008). Comparing the old and new generation SELDI-TOF MS: Implications for serum protein profiling. BMC Med Genomics 1(4):1–12.
   PubMedGoogle Scholar
• Guerrier L, Righetti PG, Boschetti E. (2008). Reduction of dynamic protein concentration range of biological extracts for the discovery of low-abundance proteins by means of hexapeptide ligand library. Nat Protoc 3(5):883–90.
   PubMed Web of Science ®Google Scholar
• Hartwig S, Czibere A, Kotzka J, Passlack W, Haas R, Eckel J, Lehr S. (2009). Combinatorial hexapeptide ligand libraries (ProteoMiner™): An innovative fractionation tool for differential quantitative clinical proteomics. Arch Physiol Biochem 115(3):155–60.
   PubMedGoogle Scholar
• Huang H, Stasyk T, Morandell S, Mogg M, Schreiber M, Feuerstein I, Huck CW, Stecher G, Bonn GK, Huber LA. (2005). Enrichment of low-abundant serum proteins by albumin/immunoglobulin G immunoaffinity depletion under partly denaturing conditions. Electrophoresis 26(14):2843–9.
   PubMed Web of Science ®Google Scholar
• Ishida Y, Yamashita K, Sasaki H, Takajou I, Kubuki Y, Morishita K, Tsubouchi H, Okayama A. (2008). Activation of complement system in adult T-cell leukemia (ATL) occurs mainly through lectin pathway:a serum proteomic approach using mass spectrometry. Cancer Lett 271(1):167–77.
   PubMed Web of Science ®Google Scholar
• Kiehntopf M, Siegmund R, Deufel T. (2008). Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations. Clin Chem Lab Med 45(11):1435–49. Review.
   Web of Science ®Google Scholar
• Kwak J, Tian-Ze M, Yoo MJ, Choi BH, Kim HG, Kim SR, Yim CY, Kwak YG. (2004). The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia. Exp Hematol 32(9):836–42.
   PubMed Web of Science ®Google Scholar
• Lehr S, Kotzka J, Avci H, Knebel B, Müller S, Hanisch FG, Jacob S, Haak C, Susanto F, Müller-Wieland D. (2005). Effect of sterol regulatory element binding protein-1a on the mitochondrial protein pattern in human liver cells detected by 2D-DIGE. Biochemistry 44(13):5117–28.
   PubMed Web of Science ®Google Scholar
• Mohamedali A, Guinn B, Sahu S, Thomas NS, Mufti GJ. (2009). Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patients. Br J Haematol 144(2):362–5.
   Google Scholar
• Purohit PV, Rocke DM. (2003). Discriminant models for high-throughput proteomics mass spectrometer data. Proteomics 3(9):1699–703.
   PubMed Web of Science ®Google Scholar
• Rai AJ, Gelfand CA, Haywood BC, Warunek DJ, Yi J, Schuchard MD, Mehigh RJ, Cockrill SL, Scott GBI, Tammen H et al. (2005). HUPO plasma proteome project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples. Proteomics 5(13):3262–77.
   PubMed Web of Science ®Google Scholar
• Thulasiraman V, Lin S, Gheorghiu L, Lathrop J, Lomas L, Hammond D, Boschetti E. (2005). Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis 26:3561–71.
   PubMed Web of Science ®Google Scholar
• Trimpin S, Inutan ED, Herath TN, McEwen CN. (2010). Matrix-assisted laser desorption/ionization mass spectrometry method for selectively producing either singly or multiply charged molecular ions. Anal Chem 82(1):11–5.
   PubMed Web of Science ®Google Scholar
• Unwin RD, Whetton AD. (2007). How will haematologists use proteomics? Blood Reviews 21(6):315–326.
   PubMed Web of Science ®Google Scholar
• Ward DG, Suggett N, Cheng Y, Wei W, Johnson H, Billingham LJ, Ismail T, Wakelam MJO, Johnson PJ, Martin A. (2006). Identification of serum biomarkers for colon cancer by proteomic analysis. Br J Cancer 94(12):1898–905.
   PubMed Web of Science ®Google Scholar